Table 8.
PT | Certolizumab Pegol | ||
---|---|---|---|
n | ROR | 95% CI | |
Pneumonia | 208 | 10.9 | 9.44–12.7* |
Herpes zoster | 119 | 25.1 | 20.8–30.4* |
Interstitial lung disease | 84 | 2.33 | 1.87–2.9* |
Pneumocystis jirovecii pneumonia | 44 | 7.83 | 5.79–10.6* |
Cellulitis | 32 | 9.16 | 6.45–13* |
Pyelonephritis | 25 | 17.9 | 12–26.6* |
Pneumonia bacterial | 24 | 8.94 | 5.96–13.4* |
Sepsis | 21 | 2.32 | 1.51–3.58* |
Pyrexia | 20 | 1.04 | 0.67–1.61 |
Colon cancer | 19 | 17.5 | 11.1–27.6* |
Note: *Signal detected.
Abbreviations: CI, confidence interval; PT, preferred terms; ROR, reporting odds ratio.